Skip to main content
. 2021 Nov 17;12:727102. doi: 10.3389/fphar.2021.727102

FIGURE 2.

FIGURE 2

Plot of Kaplan-Meier estimates of progression-free survival for the bevacizumab 7.5 mg/kg group compared with 15 mg/kg group.